OVID Health Systems
OVID Clinics Berlin is a private psychiatric practice and day clinic in Berlin Friedrichshain that delivers ketamine- and psilocybin-augmented psychotherapy, outpatient psychiatry, and intensive multi-modal day clinic programmes exclusively to privately insured and self-paying patients. The clinic operates Germany's first BfArM-approved psilocybin compassionate use programme under Prof. Dr. Gerhard Gründer.
- Company typePrivate
- Founded2020
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2C
- OfferingServices
What OVID Health Systems does
OVID Health Systems operates OVID Clinics Berlin, a private psychiatric practice and intensive day clinic located at Boxhagener Strasse 82 in Berlin Friedrichshain. The clinic delivers contemporary psychiatry, psychotherapy, and psychosomatic medicine, with a core specialisation in ketamine- and psilocybin-augmented psychotherapy. Its treatment portfolio spans outpatient consultations, an intensive 4-12 week day clinic programme with capacity for up to 16 patients, and Germany's first BfArM-approved psilocybin compassionate use programme for treatment-resistant depression under Prof. Dr. med. Gerhard Gründer. Treatment modules include guideline-based psychotherapy (behavioural, systemic, depth-psychological), mindfulness and relaxation, body and movement therapy, creative therapies (art, music, bibliotherapy), breathwork, virtual reality, and medication tapering, delivered by a multidisciplinary team operating in German, English, Spanish, and Turkish.
The business is structured across three interconnected German legal entities — OVID Clinic Berlin GmbH (private practice), OVID Tagesklinik GmbH & Co. KG (day clinic operations), and OVID Beteiligungsgesellschaft mbH (intermediate holding) — under shared management by Prof. Dr. Gerhard Gründer, Dr. Andrea Jungaberle, and Markus Kopf. Revenue is generated exclusively from privately insured (PKV), Beihilfe, and self-paying patients, as statutory health insurance (GKV) does not cover these services. Pricing is per treatment course: outpatient ketamine-augmented psychotherapy at €6,500-€7,500, day clinic programmes at €12,000-€15,000 for 4-6 weeks, and the psilocybin compassionate use programme at approximately €24,000 for 8 weeks. Distribution is direct-to-patient through the Berlin facility, supported by physician referral partnerships (a dedicated For Referrers portal and CME-accredited OVID Academy), and strategic research collaborations with Charité Berlin and the MIND Foundation stemming from the EPIsoDe study (2021-2024). The company is privately held with no disclosed external investors.
OVID Health Systems firmographics
Firmographics- Name
- OVID Health Systems
- Legal name
- OVID Clinic Berlin GmbH
- Website
- https://ovid-clinics.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- OVID Clinics Berlin is a private psychiatric practice and day clinic in Berlin Friedrichshain that delivers ketamine- and psilocybin-augmented psychotherapy, outpatient psychiatry, and intensive multi-modal day clinic programmes exclusively to privately insured and self-paying patients. The clinic operates Germany's first BfArM-approved psilocybin compassionate use programme under Prof. Dr. Gerhard Gründer.
- Ownership category
- akta.pro rank
OVID Health Systems industry classification
Industry- Product category
- Psychiatric & Psychotherapeutic Day Clinic Services
- NAICS
- Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Mental Health Practitioners (except Physicians) (621330)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Outpatient Mental Health Clinics & Counseling Centers (HLAFACAA)
- akta.pro secondary industries
- Outpatient Mental Health & Counseling Clinics (HLAFABAC), Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP) (HLAFACAJ)
Keywords
Where OVID Health Systems is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
OVID Health Systems business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Private Insurance Billing (PKV): Direct billing to private health insurers for psychiatric and psychotherapeutic treatments. Services are exclusively available to privately insured patients, with the clinic handling all insurance communications and GOÄ fee schedule billing.
- Self-Pay / Out-of-Pocket: Self-funding patients pay directly for treatments including ketamine-augmented psychotherapy (€6,500-7,500), day clinic programmes (€12,000-15,000 for 4-6 weeks), and psilocybin compassionate use (approximately €24,000 for 8 weeks).
- Civil Service Insurance (Beihilfe): Billing to civil service insurance schemes in addition to or as supplement to private insurance coverage for eligible patients.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Outpatient Ketamine-Augmented Psychotherapy (KAP): €6,500–7,500 |
| One time/ perpetual license | Pay-as-you-go | Day Clinic (with/without KAP): €12,000 minimum (4 weeks) |
| One time/ perpetual license | Pay-as-you-go | Psilocybin Compassionate Use Programme: approximately €24,000 (8 weeks fixed) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
OVID Health Systems product offering
Product offeringCore offering
OVID Clinics Berlin operates a private psychiatric practice and day clinic in Berlin Friedrichshain providing outpatient psychiatric and psychotherapeutic consultations alongside intensive 4–12 week day clinic programmes. The clinic sells ketamine-augmented psychotherapy (KAP) and Germany's first BfArM-approved psilocybin compassionate use programme for treatment-resistant depression, integrating individual therapy, group therapy, mindfulness, body therapy, creative therapies, breathwork, and virtual reality. Services are exclusively available to privately insured (PKV) patients and self-funding individuals, with no statutory health insurance coverage.
Product overview
OVID Clinic Berlin operates as an integrated private practice and day clinic for contemporary psychiatry, psychotherapy and psychosomatic medicine. The core offering consists of two main service lines: the outpatient Private Practice providing regular psychiatric and psychotherapeutic consultations, and the Day Clinic offering intensive multi-week treatment programmes (typically 4-12 weeks). Within the day clinic framework, patients receive up to three individual therapy sessions per week supplemented by group therapy, mindfulness practices, creative therapies, and body movement therapies. The clinic specializes in psychedelic-augmented psychotherapy, offering Germany's first officially approved compassionate use programme for psilocybin alongside ketamine-augmented psychotherapy (KAP). Treatment is available in German, English, Spanish and Turkish, exclusively serving privately insured patients and self-funding individuals.
Differentiator
Problem solved
Functional benefit
Brands
- Ketamine-Augmented Psychotherapy (KAP): Ketamine-augmented psychotherapeutic sessions offered in individual and group settings for treatment-resistant conditions.
- Psilocybin Compassionate Use Programme
Products and services
- OVID Private Practice — Outpatient Psychiatry & Psychotherapy Private outpatient practice for contemporary psychiatry, psychotherapy and psychosomatic medicine offering psychiatric consultations, guideline-based psychotherapy, and medication management for privately insured patients and self-funding individuals. Services delivered in German, English, Spanish and Turkish.
- OVID Day Clinic — Intensive Psychiatric Programme Intensive day hospital treatment programme lasting 4–12 weeks, providing up to three individual psychotherapy sessions per week combined with group therapy, mindfulness, body & movement therapy, creative therapies, specialist psychiatric care, and optional psychedelic-augmented psychotherapy. Capacity for up to 16 patients simultaneously.
- Ketamine-Augmented Psychotherapy (KAP) Clinically rigorous ketamine-augmented psychotherapy combining ketamine administration with intensive psychotherapeutic support to dissolve entrenched thought patterns and promote neural plasticity. Offered in individual and group settings at €6,500–7,500 per course.
- Psilocybin Compassionate Use Programme Germany's first officially approved compassionate use programme with psilocybin for treatment-resistant depression, led by Prof. Dr. med. Gerhard Gründer under BfArM approval. Delivered as a multi-week day clinic treatment at approximately €24,000 for an 8-week programme.
- Medication Tapering Service Needs-oriented, medically supervised discontinuation of psychiatric medication (antidepressants, neuroleptics) integrated within the clinic's treatment approach.
Quantifiable outcome
- EPIsoDe study: Largest psilocybin therapy study for treatment-resistant depression in Germany, conducted at Central Institute of Mental Health Mannheim in collaboration with Charité Berlin and MIND Foundation (2021–2024)
Companies that use OVID Health Systems
Customer profileSegments3 records
Ideal customer profiles3 records
OVID Health Systems technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
OVID Health Systems partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- MIND FoundationcoreNonprofit partner organization dedicated to research and education in mental health. MIND promotes the legal, safe, and evidence-based use of psychedelics in therapy and human development. The partnership supports OVID's clinical work and research activities, including the EPIsoDe study collaboration. MIND is listed as a partner on the clinic's website and referenced in media coverage.
- Charité BerlincorePartnership with Prof. Dr. Wattjes and his team at Charité for imaging techniques and diagnostics. Clinical collaboration supporting comprehensive patient assessment and treatment planning. Charité is one of Europe's largest university hospitals.
- It's ComplicatedminorMental-health platform that connects clients with vetted therapists for online and in-person sessions. Partnership improves access to psychotherapeutic care for broader patient population.
- DATPPP e.V.minorGerman Association of Part-Time Psychiatric, Psychotherapy, and Psychosomatic Facilities. Professional association committed to the further development and quality assurance of part-time inpatient care. Supports professional standards and networking.
- Blaupause Therapy & CoachingminorHolistic private practice in Berlin offering integrated coaching and body-psychotherapy for mental clarity, resilience, and personal development. Inter-referral relationship for complementary care.
- Dr. Maria Schefter & Psychotherapeut:InnenminorPrivate practice for psychotherapy, trauma therapy, EMDR, and coaching located in Berlin-Mitte and Berlin-Prenzlauer Berg. Inter-referral relationship for complementary therapeutic services.
- Dr. Viola Kappel & ColleaguesminorPrivate practice in Berlin-Schöneberg led by Dr. phil. Dipl.-Psych. Viola Kappel offering specialized behavioral therapy, trauma therapy, couples therapy, diagnostics, and coaching on-site and online.
- Freiraum Psychotherapie BerlinminorCognitive behavioral therapy practice supporting people in Berlin-Friedrichshain with evidence-based, empathic psychotherapy. Geographic proximity and complementary therapeutic approach support inter-referral.
- nu.well Psychotherapy & CoachingminorModern practice in Berlin-Charlottenburg offering psychotherapeutic support and individual coaching for individuals, couples, and groups. Inter-referral relationship for complementary services.
- Psychotherapy KöhneminorBerlin-based private practice led by Dr. Svenja Köhne offering evidence-based behavioral therapy and individual psychological counseling for adults.
- Therapie FriedrichshainminorPrivate practice in Berlin offering individual psychotherapeutic treatments for adults. Geographic proximity to OVID's Friedrichshain location supports inter-referral for complementary care.
- Friesenplatz Day ClinicminorPrivate, part-time facility in Cologne offering specialized programs for mental illnesses such as depression, anxiety, and trauma-related disorders. Inter-clinic referral relationship for patients requiring care in different geographic locations.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
OVID Health Systems competitors and assessment
Company assessmentBroad incumbents
- Asklepios Kliniken: One of Germany's largest private hospital operators with significant psychiatric and psychosomatic service lines across multiple sites. Comparable as a large multi-site German psychiatric provider, though lacking OVID's psychedelic specialization.
- Median Kliniken: Major German private rehabilitation and psychosomatic clinic chain. Comparable as a German private-pay psychiatric/psychosomatic day-clinic operator, though primarily conventional rather than psychedelic-augmented therapy.
- atai Life Sciences: Clinical-stage biopharmaceutical platform developing psychedelic and non-psychedelic mental health therapies. Operates a portfolio of psychedelic programmes (including VLS-01, DM-001) and shares OVID's psychedelic-augmented therapy thesis but at much larger scale and broader indication set.
- Schoen Clinic: Germany's largest family-run hospital group with extensive psychiatric and psychosomatic inpatient and day-clinic services. Comparable as a German psychiatric care provider with day-clinic infrastructure, though focused on conventional rather than psychedelic-augmented therapy.
Direct peers
- Compass Pathways: Publicly listed developer of psilocybin therapy (COMP360) for treatment-resistant depression. Directly comparable as a European-headquartered, clinical-stage psychedelic-assisted therapy company targeting the same TRD patient population with regulatory-first positioning.
- GH Research: Clinical-stage company developing mebufotenin (5-MeO-DMT) and other psychedelic therapies for TRD. Directly comparable as a psychedelic-focused TRD company with regulatory/clinical-trial positioning parallel to OVID's psilocybin programme.
Emerging players
- Clerkenwell Health: UK-based psychedelic clinical trials company running therapy trials for depression and other indications. Comparable as a European psychedelic-therapy clinical operator, though focused on trial delivery rather than commercial patient treatment.
- Awakn Life Sciences: UK/Canada-based clinical-stage company developing psychedelic-assisted therapies for addiction and mental health disorders. Comparable as an emerging European psychedelic-therapy operator with overlapping clinical indications (depression, addiction).
- Synthesis Institute: Netherlands-based psychedelic therapy training and retreat organization offering psilocybin truffle programmes in a legal Dutch framework. Comparable as a European commercial psychedelic-therapy provider, though operating under Dutch psilocybin-truffle regulation rather than German medical pathways.
- MIND Foundation: Berlin-based nonprofit research and education organization for psychedelic-assisted therapy, OVID's stated partner. Comparable as a European psychedelic-therapy ecosystem player; MIND focuses on training, research, and education while OVID delivers clinical treatment.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
OVID Health Systems social profiles
Digital presenceOVID Health Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
OVID Health Systems leadership team
Management profileNumber of profiles
Profiles5 records
OVID Health Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
OVID Health Systems M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about OVID Health Systems
What does OVID Health Systems do?
OVID Clinics Berlin operates a private psychiatric practice and day clinic in Berlin Friedrichshain providing outpatient psychiatric and psychotherapeutic consultations alongside intensive 4–12 week day clinic programmes. The clinic sells ketamine-augmented psychotherapy (KAP) and Germany's first BfArM-approved psilocybin compassionate use programme for treatment-resistant depression, integrating individual therapy, group therapy, mindfulness, body therapy, creative therapies, breathwork, and virtual reality. Services are exclusively available to privately insured (PKV) patients and self-funding individuals, with no statutory health insurance coverage.
Is OVID Health Systems a public or private company?
OVID Health Systems is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was OVID Health Systems founded?
OVID Health Systems was founded in 2020. It employs 1 to 10 people.
Where is OVID Health Systems based?
OVID Health Systems is headquartered in Berlin, Germany, in the Europe region.
How does OVID Health Systems make money?
Three revenue lines are on record. Private Insurance Billing (PKV) is the primary driver. The others are self-Pay / Out-of-Pocket and civil Service Insurance (Beihilfe).
Who are OVID Health Systems's main competitors?
Broad incumbents on record are Asklepios Kliniken, Median Kliniken, atai Life Sciences and Schoen Clinic. Direct peers are Compass Pathways and GH Research. Emerging players are Clerkenwell Health, Awakn Life Sciences, Synthesis Institute and MIND Foundation.
Does OVID Health Systems have an API?
No public API is recorded for OVID Health Systems.
What industry is OVID Health Systems in?
OVID Health Systems's product category is Psychiatric & Psychotherapeutic Day Clinic Services. Its primary akta.pro industry code is HLAFACAA, Outpatient Mental Health Clinics & Counseling Centers, with a secondary code of HLAFABAC, Outpatient Mental Health & Counseling Clinics. Its NAICS code is 621112 and its SIC code is 8011.